Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
7.84
-0.72 (-8.41%)
At close: Mar 6, 2026, 4:00 PM EST
7.88
+0.04 (0.51%)
After-hours: Mar 6, 2026, 7:41 PM EST
Personalis Employees
As of December 31, 2025, Personalis had 260 total employees, including 259 full-time and 1 part-time employees. The number of employees increased by 31 or 13.54% compared to the previous year.
Employees
260
Change (1Y)
31
Growth (1Y)
13.54%
Revenue / Employee
$267,877
Profits / Employee
-$312,577
Market Cap
820.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Neogen | 2,974 |
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| GRAIL | 1,000 |
| Twist Bioscience | 979 |
PSNL News
- 9 days ago - Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights - Business Wire
- 18 days ago - Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference - Business Wire
- 23 days ago - Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 25 days ago - Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance - Business Wire
- 4 weeks ago - Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors - Business Wire
- 5 weeks ago - Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Business Wire
- 7 weeks ago - Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™ - Business Wire